Inside informationEnglish
VALBIOTIS SA: Valbiotis announces completion of recruitment for the Cardio-Liver clinical study conducted with TOTUM•448 for metabolic liver diseases (MASLD)
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Valbiotis
- Filed
- 08/12/2025, 17:40
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 007809_20251208